全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

青春期起病的17α-羟化酶/17,20-碳链裂解酶缺陷症一例及文献复习
Pubertal Onset of 17α-Hydroxylase/17, 20-Lyase Deficiency: A Case Report and Literature Review

DOI: 10.12677/acrp.2025.133003, PP. 11-18

Keywords: 17α-羟化酶/17,20-碳链裂解酶缺陷症,先天性肾上腺皮质增生症,低肾素性高血压,原发性闭经
17α-Hydroxylase/17
, 20-Lyase Deficiency, Congenital Adrenal Hyperplasia, Hyporenin Hypertension, Primary Amenorrhea

Full-Text   Cite this paper   Add to My Lib

Abstract:

目的:探讨17α-羟化酶/17,20-碳链裂解酶缺陷症(17α-hydroxylase/17, 20-lyase deficiency, 17-OHD)患者的临床表现、实验室检查、治疗及预后。方法:回顾性分析1例初期疑诊为原发性醛固酮增多症的17-OHD患者的临床资料,并复习相关文献。结果:患儿,社会性别女,14岁9月时剧烈运动后出现肌肉酸痛、乏力纳差并进行性加重,外院测血压峰值180/110mmHg,血钾及卧位肾素水平降低,卧位醛固酮/肾素浓度升高,肾上腺CT示双侧肾上腺增生,疑诊原发性醛固酮增多症。15岁2月时因无月经初潮至我院就诊发现晨8点促肾上腺皮质激素、孕烯醇酮、11-脱氧皮质酮、皮质酮升高,晨8点皮质醇、睾酮和雌二醇水平降低。全外显子分析发现患儿CYP17A1基因存在c985_987delTACinsAA和c.979_981delAAG杂合变异,均为已知致病性突变,确诊17α-羟化酶缺陷症。经激素替代治疗和降压药物应用,患儿目前血压控制良好。结论:对于影像学发现双侧肾上腺增生的高血压患者,即使青春期以后甚至成年发病,仍应警惕先天性肾上腺皮质增生症的可能。
Objective: To investigate the clinical manifestations, laboratory features, treatment and prognosis of patients with 17α-hydroxylase/17, 20-lyase deficiency. Methods: Analyze the clinical data of a patient with 17α-hydroxylase/17,20-lyase deficiency retrospectively who was initially suspected of primary aldosteronism and conduct a review in conjunction with relevant literature. Results: The patient was a girl who suffered from progressive myalgia, fatigue and poor appetite after strenuous exercise at the age of 14 years and 9 months. The peak blood pressure was 180/110 mmHg, which was measured in the external hospital, and the blood potassium and recumbent renin levels decreased, while the recumbent aldosterone/renin concentration increased. Adrenal CT showed bilateral adrenal hyperplasia, and then primary aldosteronism was suspected. She came to our hospital because of amenorrhoea at the age of 15 years and 2 months. Then we found that the levels of adreno-cortico-tropic-hormone at 8 am, pregnenolone, 11-deoxycorticosterone and corticosterone increased while the levels of cortisol at 8 am, testosterone and estradiol decreased. The whole exome sequencing showed that there were compound heterozygous mutations of c985_987delTACinsAA and c.979_981delAAG in CYP17A1 gene in this patient, both of which were known as pathogenic mutations, and she was diagnosed as 17α-hydroxylase deficiency. The blood pressure of the patient is well controlled after hormone replacement therapy and the application of hypotensive drugs. Conclusion: For hypertensive patients with bilateral adrenal hyperplasia, we should pay attention to the possibility of rare subtypes of congenital adrenal hyperplasia even though they come to clinic in adolescence or adulthood.

References

[1]  Biglieri, E.G., Herron, M.A. and Brust, N. (1966) 17-Hydroxylation Deficiency in Man. Journal of Clinical Investigation, 45, 1946-1954.
https://doi.org/10.1172/jci105499
[2]  Li, J., Zhang, Q., Chen, J., Fu, X., Yang, J. and Liu, L. (2022) Case Report: 17α− Hydroxylase Deficiency Due to a Hotspot Variant and a Novel Compound Heterozygous Variant in the CYP17A1 Gene of Five Chinese Patients. Frontiers in Pediatrics, 10, Article 935191.
https://doi.org/10.3389/fped.2022.935191
[3]  Costa-Santos, M., Kater, C.E. and Auchus, R.J. (2004) Two Prevalent cyp17 Mutations and Genotype-Phenotype Correlations in 24 Brazilian Patients with 17-Hydroxylase Deficiency. The Journal of Clinical Endocrinology & Metabolism, 89, 49-60.
https://doi.org/10.1210/jc.2003-031021
[4]  Espinosa-Herrera, F., Espín, E., Tito-Álvarez, A.M., Beltrán, L., Gómez-Correa, D., Burgos, G., et al. (2019) A Report of Congenital Adrenal Hyperplasia Due to 17α-Hydroxylase Deficiency in Two 46, XX Sisters. Gynecological Endocrinology, 36, 24-29.
https://doi.org/10.1080/09513590.2019.1650342
[5]  Wei, J., Wei, J., Li, W., Bi, Y. and Wei, F. (2006) Genotyping of Five Chinese Patients with 17α-Hydroxylase Deficiency Diagnosed through High-Performance Liquid Chromatography Serum Adrenal Profile: Identification of Two Novel CYP17 Mutations. The Journal of Clinical Endocrinology & Metabolism, 91, 3647-3653.
https://doi.org/10.1210/jc.2006-0153
[6]  宋福英, 刘子勤, 刘颖, 等. 儿童17α-羟化酶/17, 20碳链裂解酶缺陷症6例临床及CYP17A1基因突变分析[J]. 中华实用儿科临床杂志, 2021, 36(8): 609-612.
[7]  Auchus, R.J. (2001) The Genetics, Pathophysiologx, and Management of Human Deficiencies of P450c17. Endocrinology and Metabolism Clinics of North America, 30, 101-119.
https://doi.org/10.1016/s0889-8529(08)70021-5
[8]  Auchus, R.J. (2017) Steroid 17-Hydroxylase and 17, 20-Lyase Deficiencies, Genetic and Pharmacologic. The Journal of Steroid Biochemistry and Molecular Biology, 165, 71-78.
https://doi.org/10.1016/j.jsbmb.2016.02.002
[9]  Zhang, M., Sun, S., Liu, Y., Zhang, H., Jiao, Y., Wang, W., et al. (2015) New, Recurrent, and Prevalent Mutations: Clinical and Molecular Characterization of 26 Chinese Patients with 17α-Hydroxylase/17, 20-Lyase Deficiency. The Journal of Steroid Biochemistry and Molecular Biology, 150, 11-16.
https://doi.org/10.1016/j.jsbmb.2015.02.007
[10]  陶红, 陆召麟, 张波, 等. 17α-羟化酶/17, 20-裂解酶缺陷症的临床特点及长期随诊资料分析[J]. 中华内科杂志, 2005(6): 442-445.
[11]  Tian, Q., Zhang, Y. and Lu, Z. (2008) Partial 17α-Hydroxylase/17, 20-Lyase Deficiency-Clinical Report of Five Chinese 46, XX Cases. Gynecological Endocrinology, 24, 362-367.
https://doi.org/10.1080/09513590802194051
[12]  Jiang, S., Xu, Y., Qiao, J., Wang, Y. and Kuang, Y. (2022) Reproductive Endocrine Characteristics and in Vitro Fertilization Treatment of Female Patients with Partial 17α-Hydroxylase Deficiency: Two Pedigree Investigations and a Literature Review. Frontiers in Endocrinology, 13, Article 970190.
https://doi.org/10.3389/fendo.2022.970190
[13]  Yao, F., Huang, S., Kang, X., Zhang, W., Wang, P. and Tian, Q. (2012) CYP17A1 Mutations Identified in 17 Chinese Patients with 17α-Hydroxylase/17, 20-Lyase Deficiency. Gynecological Endocrinology, 29, 10-15.
https://doi.org/10.3109/09513590.2012.705373
[14]  Xia, Y., Shi, P., Xia, J., Zhang, H., Xu, L. and Kong, X. (2021) Novel Mutations of the CYP17A1 Gene in Four Chinese 46, XX Cases with Partial 17a-Hydroxylase/17, 20-Lyase Deficiency. Steroids, 173, Article ID: 108873.
https://doi.org/10.1016/j.steroids.2021.108873
[15]  Winter, J.S.D., Couch, R.M., Muller, J., Perry, Y.S., Ferreira, P., Baydala, L., et al. (1989) Combined 17-Hydroxylase and 17, 20-Desmolase Deficiencies: Evidence for Synthesis of a Defective Cytochrome P450c17. The Journal of Clinical Endocrinology & Metabolism, 68, 309-316.
https://doi.org/10.1210/jcem-68-2-309
[16]  Xue, L., Han, B., Chen, L., Pan, C., Zhu, H., Liu, B., et al. (2013) Identification of a Novel Mutation in CYP17A1 Gene. Translational Research, 161, 44-49.
https://doi.org/10.1016/j.trsl.2012.08.007
[17]  Xu, S., Hu, S., Yu, X., Zhang, M. and Yang, Y. (2016) 17α-Hydroxylase/17, 20-Lyase Deficiency in Congenital Adrenal Hyperplasia: A Case Report. Molecular Medicine Reports, 15, 339-344.
https://doi.org/10.3892/mmr.2016.6029
[18]  Rosa, S., Duff, C., Meyer, M., Lang-Muritano, M., Balercia, G., Boscaro, M., et al. (2007) P450c17 Deficiency: Clinical and Molecular Characterization of Six Patients. The Journal of Clinical Endocrinology & Metabolism, 92, 1000-1007.
https://doi.org/10.1210/jc.2006-1486
[19]  Unwin, R.J., Luft, F.C. and Shirley, D.G. (2011) Pathophysiology and Management of Hypokalemia: A Clinical Perspective. Nature Reviews Nephrology, 7, 75-84.
https://doi.org/10.1038/nrneph.2010.175
[20]  de Simone, G., Mancusi, C., Hanssen, H., Genovesi, S., Lurbe, E., Parati, G., et al. (2022) Hypertension in Children and Adolescents. European Heart Journal, 43, 3290-3301.
https://doi.org/10.1093/eurheartj/ehac328
[21]  中华医学会内分泌学分会. 原发性醛固酮增多症诊断治疗的专家共识(2020版) [J]. 中华内分泌代谢杂志, 2020, 36(9): 727-736.
[22]  Knochel, J.P. (1982) Neuromuscular Manifestations of Electrolyte Disorders. The American Journal of Medicine, 72, 521-535.
https://doi.org/10.1016/0002-9343(82)90522-8
[23]  Zavatto, A., Concistrè, A., Marinelli, C., et al. (2015) Hypokalemic Rhabdomyolysis: A Rare Manifestation of Primary Aldosteronism. European Review for Medical and Pharmacological Sciences, 19, 3910-3916.
[24]  Allison, R.C. and Lawrence Bedsole, D. (2003) The Other Medical Causes of Rhabdomyolysis. The American Journal of the Medical Sciences, 326, 79-88.
https://doi.org/10.1097/00000441-200308000-00005
[25]  Chen, H., Yuan, K., Zhang, B., Jia, Z., Chen, C., Zhu, Y., et al. (2019) A Novel Compound Heterozygous CYP17A1 Variant Causes 17α-Hydroxylase/17, 20-Lyase Deficiency. Frontiers in Genetics, 10, Article 996.
https://doi.org/10.3389/fgene.2019.00996
[26]  Yamakita, N., Murase, H., Yasuda, K., Noritake, N., Mercado-Asis, L.B. and Miura, K. (1989) Possible Hyperaldosteronism and Discrepancy in Enzyme Activity Deficiency in Adrenal and Gonadal Glands in Japanese Patients with 17α-Hydroxylase Deficiency. Endocrinologia Japonica, 36, 515-536.
https://doi.org/10.1507/endocrj1954.36.515
[27]  Hinz, L., Pacaud, D. and Kline, G. (2017) Congenital Adrenal Hyperplasia Causing Hypertension: An Illustrative Review. Journal of Human Hypertension, 32, 150-157.
https://doi.org/10.1038/s41371-017-0002-5
[28]  Zhao, Z., Lu, L., Wang, O., Wu, X., Sun, B., Zhang, W., et al. (2022) High Incidence of Hypertension-Mediated Organ Damage in a Series of Chinese Patients with 17α-Hydroxylase Deficiency. Endocrine, 76, 151-161.
https://doi.org/10.1007/s12020-021-02966-w
[29]  王含必, 田秦杰, 孙爱军, 等. 完全型17α羟化酶缺乏48例临床分析[J]. 中华妇产科杂志, 2012(7): 518-521.
[30]  Bee, Y.M., Manju, C., Papari-Zareei, M. and Auchus, R.J. (2011) Phenotypic Variation in a Chinese Family with 46, XY and 46, XX 17α-Hydroxylase Deficiency. Gynecological Endocrinology, 28, 322-325.
https://doi.org/10.3109/09513590.2011.631625
[31]  Wang, Y., Zhao, Y., Zhou, G. and He, B. (2014) CYP17A1 Gene Mutations and Hypertension Variations Found in 46, XY Females with Combined 17α-Hydroxylase/17, 20-Lyase Deficiency. Gynecological Endocrinology, 30, 456-460.
https://doi.org/10.3109/09513590.2014.895980
[32]  Yanase, T., Simpson, E.R. and Waterman, M.R. (1991) 17α-Hydroxylase/17, 20-Lyase Deficiency: From Clinical Investigation to Molecular Definition. Endocrine Reviews, 12, 91-108.
https://doi.org/10.1210/edrv-12-1-91

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133